More on KYMR

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (9.0 Score)
- Holders

Upcoming Events

- Earnings (7/31/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Kymera Therapeutics (NQ:KYMR)
Delayed: 115.77 +1.78 (1.56%)
Prev. Close $113.99  
Open$111.76 
52 Wk High$ 
52 Wk Low$ 
Day High$117.00 
Day Low$110.41 
P/E N/A  
EPS$ 
Volume720,688 

Friends, Peers and Foes (?): ASND, BIIB, DYN, GILD, XENE (more...)

Jul 16, 2026 05:29 AM Kymera Therapeutics (KYMR) PT Raised to $140 at Mizuho
Jul 13, 2026 02:07 PM Kymera Therapeutics (KYMR) call put ratio 1 call to 3.3 puts with a focus on December 95 and 100 puts as share price down 8%
Jul 7, 2026 08:01 PM Form 4 Kymera Therapeutics, For: Jul 07 Filed by: Mainolfi Nello
Jul 7, 2026 04:07 PM Form 144 Kymera Therapeutics, Filed by: Mainolfi Nello
Jul 7, 2026 07:00 AM Kymera Therapeutics names ex-Sanofi executive to lead KT-621 program
Jul 7, 2026 07:00 AM Kymera Therapeutics Appoints Elizabeth Laws, Ph.D., as Senior Vice President, Global Program Team Leader for KT-621, First-in-Class, Oral STAT6 Degrader
Jul 2, 2026 06:30 PM Form 4 Kymera Therapeutics, For: Jul 01 Filed by: Goodman Noah
Jul 2, 2026 06:30 PM Form 4 Kymera Therapeutics, For: Jul 01 Filed by: Mainolfi Nello
Jul 2, 2026 06:30 PM Form 4 Kymera Therapeutics, For: Jun 30 Filed by: Jacobs Bruce N.
Jul 2, 2026 05:39 PM Form 4/A Kymera Therapeutics, For: Jun 26 Filed by: Booth Bruce
View All Articles

Entities mentioned with KYMR

View All Entities